Treatment of Allergic Patients with Adenotonsillar Hypertrophy: Surgery Versus Medication Therapy
DOI:
https://doi.org/10.31661/gmj.v11i.2317Keywords:
Allergic, Adenotonsillar Hypertrophy, Medication, TonsillectomyAbstract
Background: Adenotonsillar hypertrophy (AH) is the most common cause of respiratory obstruction of the upper airway, and tonsillectomy is one of the most frequently performed surgical interventions in children. It has been proposed that medical treatment in an allergic state could decrease the size of AH. Therefore, this study aimed to compare the outcomes of surgery and medical therapies among allergic children with AH. Materials and Methods: This case-control study was carried out on 68 children with AH in an allergic state who were referred to the Pediatrics Hospital of Tabriz Medical University. They were divided into two groups and matched according to sex, age, and primary clinical signs and symptoms. Patients received surgery (case group) and medication (control groups) for treated AH. Finally, they were compared according to the results of treatment and recurrence rate. Results: The mean age of children in the case and control groups was 6.3±2.3 and 6.8±2.1 years, respectively. There was no significant difference in improving clinical signs and symptoms between the two groups. In the case group, no improvement of clinical signs and symptoms was observed in one patient compared with two patients in the control group. In the control group, no decrease in the size of the tonsils was observed in three patients. Recurrence of clinical signs of AH was observed in six (17.6%) patients of the control group, and there was a significant difference between the two groups (P<0.001). Conclusion: Our findings showed no significant differences in the outcomes of the two therapeutic methods for AH in an allergic state. However, medical treatment needs a long time to affect, but surgery can act quickly. Recurrence of AH after medical therapy could occur.
References
Brambilla I, Pusateri A, Pagella F, Caimmi D, Caimmi S, Licari A, et al. Adenoids in children: advances in immunology, diagnosis, and surgery. Clin Anat. 2014;27(3):346-52. https://doi.org/10.1002/ca.22373PMid:24535951 Brambilla I, Manti S, Savasta S, Valsecchi C, Caimmi SM, Marseglia GL, et al. Adenoidal Immune Response in the Context of Inflammation and Allergy. Current Respiratory Medicine Reviews. 2019;15(3):231-7. https://doi.org/10.2174/1573398X15666190703110843 Buskens E, Van Staaij B, Van Den Akker J, Hoes AW, Schilder AG. Adenotonsillectomy or watchful waiting in patients with mild to moderate symptoms of throat infections or adenotonsillar hypertrophy: a randomized comparison of costs and effects. Arch Otolaryngol Head Neck Surg. 2007;133(11):1083-8. https://doi.org/10.1001/archotol.133.11.1083PMid:18025310 Shen L, Zheng B, Lin Z, Xu Y, Yang Z. Tailoring therapy to improve the treatment of children with obstructive sleep apnea according to grade of adenotonsillar hypertrophy. Int J Pediatr Otorhinolaryngol. 2015;79(4):493-8. https://doi.org/10.1016/j.ijporl.2015.01.005PMid:25649714 Colavita L, Miraglia MDG, Stroscio G, Visalli C, Alterio T, Pidone C, et al. Allergic rhinitis and adenoid hypertrophy in children: is adenoidectomy always really useful? J Biol Regul Homeost Agents. 2015;29(1):58-63. Tatlıpınar A, Duman D, Uslu C, Egeli E. The effects of obstructive sleep apnea syndrome due to adenotonsillar hypertrophy on the cardiovascular system in children. Turk J Pediatr. 2011;53:359-63. Orji FT, Adiele DK, Umedum NG, Akpeh JO, Ofoegbu VC, Nwosu JN. The clinical and radiological predictors of pulmonary hypertension in children with adenotonsillar hypertrophy. Eur Arch Otorhinolaryngol. 2017;274(3):1237-43. https://doi.org/10.1007/s00405-016-4207-yPMid:27430227 Cincin A, Sakalli E, Bakirci EM, Dizman R. Relationship between obstructive sleep apnea-specific symptoms and cardiac function before and after adenotonsillectomy in children with adenotonsillar hypertrophy. Int J Pediatr Otorhinolaryngol. 2014;78(8):1281-7. https://doi.org/10.1016/j.ijporl.2014.05.011PMid:24880923 Kara CO, Ergin H, Koçak G, Kılıç Il, Yurdakul M. Prevalence of tonsillar hypertrophy and associated oropharyngeal symptoms in primary school children in Denizli, Turkey. Int J Pediatr Otorhinolaryngol. 2002;66(2):175-9. https://doi.org/10.1016/S0165-5876(02)00247-1PMid:12393253 Karaca CT, Toros SZ, Noseri H, Kulekci S, Kalayck C, Oysu C, et al. Role of allergy in children with adenotonsillar hypertrophy. J Craniofac Surg. 2012;23(6):e611-3. https://doi.org/10.1097/SCS.0b013e31826cf562PMid:23172495 Pereira L, Monyror J, Almeida FT, Almeida FR, Guerra E, Flores-Mir C, et al. prevalence of adenoid hypertrophy: A systematic review and meta-analysis. Sleep Med Rev. 2018;38:101-12. https://doi.org/10.1016/j.smrv.2017.06.001PMid:29153763 Zhang X, Sun B, Li S, Jin H, Zhong N, Zeng G. Local atopy is more relevant than serum s Ig E in reflecting allergy in childhood adenotonsillar hypertrophy. Pediatr Allergy Immunol. 2013;24(5):422-6. https://doi.org/10.1111/pai.12089PMid:23724785 Venekamp RP, Hearne BJ, Chandrasekharan D, Blackshaw H, Lim J, Schilder AGM. Tonsillectomy or adenotonsillectomy versus nonâ€surgical management for obstructive sleepâ€disordered breathing in children. Cochrane Database Syst Rev. 2015;2015(10): CD011165. https://doi.org/10.1002/14651858.CD011165.pub2 Lou Z. Adenoid hypertrophy in children and allergic rhinitis. Eur Arch Otorhinolaryngol. 2018;275(3):831-2. https://doi.org/10.1007/s00405-017-4737-yPMid:28887688 Evcimik MF, Dogru M, Cirik AA, Nepesov MI. Adenoid hypertrophy in children with allergic disease and influential factors. Int J Pediatr Otorhinolaryngol. 2015;79(5):694-7. https://doi.org/10.1016/j.ijporl.2015.02.017PMid:25758194 Eren E, Arslanoglu S, Erdem SB, Nacaroglu T, Karkiner CS, Can D, et al. Chicken or the egg: the dilemma of allergic rhinitis versus adenoid hypertrophy. Rhinology. 2015;53(2):154-9. https://doi.org/10.4193/Rhino14.013PMid:26030038 Cho K-S, Kim SH, Hong S-L, Lee J, Mun SJ, Roh YE, et al. Local atopy in childhood adenotonsillar hypertrophy. Am J Rhinol Allergy. 2018;32(3):160-6. https://doi.org/10.1177/1945892418765003PMid:29649882 Kuhle S, Hoffmann DU, Mitra S, Urschitz MS. Antiâ€inflammatory medications for obstructive sleep apnoea in children. Cochrane Database Syst Rev. 2020;1(1):CD007074. https://doi.org/10.1002/14651858.CD007074.pub3PMid:31978261 PMCid:PMC6984442 Kar M, Altıntoprak N, Muluk NB, Ulusoy S, Bafaqeeh SA, Cingi C. Antileukotrienes in adenotonsillar hypertrophy: a review of the literature. Eur Arch Otorhinolaryngol 2016;273(12):4111-7. https://doi.org/10.1007/s00405-016-3983-8PMid:26980339 Kheirandish-Gozal L, Kim J, Goldbart AD, Gozal D. Novel pharmacological approaches for treatment of obstructive sleep apnea in children. Expert Opin Investig Drugs. 2013;22(1):71-85. https://doi.org/10.1517/13543784.2013.735230PMid:23126687 Sakarya E, Muluk NB, Sakalar E, Senturk M, Aricigil M, Bafaqeeh S, et al. Use of intranasal corticosteroids in adenotonsillar hypertrophy. J Laryngol Otol. 2017;131(5):384-90. https://doi.org/10.1017/S0022215117000408PMid:28238295 Chohan A, Lal A, Chohan K, Chakravarti A, Gomber S. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children. Int J Pediatr Otorhinolaryngol. 2015;79(10):1599-608. https://doi.org/10.1016/j.ijporl.2015.07.009PMid:26235732 Zhang L, Mendozaâ€Sassi RA, César JA, Chadha NK. Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy. Cochrane Database Syst Rev. 2008;2008(3):CD006286. https://doi.org/10.1002/14651858.CD006286.pub2PMid:18646145 PMCid:PMC8923350 Criscuoli G, D'Amora S, Ripa G, Cinquegrana G, Mansi N, Impagliazzo N, et al. Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone. Pediatrics. 2003;111(3):e236-8. https://doi.org/10.1542/peds.111.3.e236PMid:12612277 Ciprandi G, Varricchio A, Capasso M, Varricchio A, De Lucia A, Ascione E, et al. Intranasal flunisolide treatment in children with adenoidal hypertrophy. Int J Immunopathol Pharmacol. 2007;20(4):833-6. https://doi.org/10.1177/039463200702000420PMid:18179756 Huang S-W, Giannoni C. The risk of adenoid hypertrophy in children with allergic rhinitis. Ann Allergy Asthma Immunol. 2001;87(4):350-5. https://doi.org/10.1016/S1081-1206(10)62251-XPMid:11686429 ModrzyÅ„ski M, Zawisza E. Frequency of adenoid hypertrophy in children with allergic diseases. Przegl Lek. 2003;60(5):322-4. Joshua B, Bahar G, Sulkes J, Shpitzer T, Raveh E. Adenoidectomy: long-term follow-up. Otolaryngol Head Neck Surg. 2006;135(4):576-80. https://doi.org/10.1016/j.otohns.2006.05.027PMid:17011420 Griffin JL, Ramadan HH, Adham RE. Prevalence of IgE-mediated hypersensitivity in children with adenotonsillar disease. Arch Otolaryngol Head Neck Surg. 1994;120(2):150-3. https://doi.org/10.1001/archotol.1994.01880260022005PMid:8297571 Scadding G. Nonâ€surgical treatment of adenoidal hypertrophy: the role of treating IgEâ€mediated inflammation. Pediatr Allergy Immunol. 2010;21(8):1095-106. https://doi.org/10.1111/j.1399-3038.2010.01012.xPMid:20609137
